Experimentica Ltd. receives French CIR accreditation

Summary: From now on, France's Crédit d'Impôt Recherche incentive can cover up to 30% of R&D expenses incurred by innovative French pharma and biotech companies working with us.

CIR accreditation will translate into a significant financial benefit to Experimentica’s customers in France. This incentive will help bring our expertise to a broader number of companies developing drugs in Ophthalmology.

Content

We noticed how challenging it is for Executives to find new research partners with world-class expertise while facing financial constraints and adverse fundraising trends.

That is why Experimentica’s CIR accreditation is excellent news to French pharma and biotech companies developing preclinical assets in Ophthalmology. This tax incentive will translate into a significant financial benefit to our customers in France and will allow us to bring our expertise to a broader number of innovative companies.

Reach out to our BD Director Guillaume Demarne for inquiries, by email at gd@experimentica.com or by phone at +33 (0) 7 83 55 69 52.

References

Press Release: Experimentica Ltd. receives French Crédit d’Impôt Recherche (CIR) accreditation for 2020-2022 (PDF)
CIR Accreditation: Experimentica’s CIR Accreditation for 2020-2022 from French Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation (PDF)